Pre-Open 10/01: (GERN) (ADT) (MNK) Higher (NERV) (AMTD) (ETFC) Lower (more...)
Today's Pre-Open MoversMinerva Neurosciences, Inc. (NASDAQ: NERV) 25.2% LOWER; announced an update on three clinical-stage programs with roluperidone (MIN-101), seltorexant ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)